Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01624064

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01624064
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sri Lanka (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01624064. Randomized; quadruple masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2012-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology
Acronym
CKDu
Condition
Renal Insufficiency, Chronic
Intervention (Drug)
Enalapril
Intervention (Drug)
Calcium Supplement
Lead sponsor
Ministry of Health, Sri Lanka (class: other government)
Collaborator
World Health Organization (class: other)

Record details

Record id
cardio:ct-nct01624064
Content hash
8692d47fa525f9cb425a1b02f6862f9bf8291c048c4a98affe6a8c385585cc14